The innate immune system is an evolutionary conserved first line of defense against invading organisms. It is now well established that the innate immune system uses molecular pattern recognition to detect infection and mount an immune response to eliminate the pathogen and infected cells. Specialized receptors collectively called pathogen- or pattern-recognition receptors (PRRs) are present on the cytoplasmic or endosomal membranes, or in the cell cytosol [@R1], [@R2]. PRRs sense highly conserved molecular components of invading organisms known as pathogen-associated molecular patterns (PAMPs).

A recently identified PRR called AIM2 (absent in melanoma 2), was found to recognize cytoplasmic dsDNA through its HIN-200 domain[@R3]--[@R6]. AIM2 assembles a large inflammasome complex with cytosolic DNA, visible by confocal microscopy [@R3]. The fully assembled AIM2 inflammasome then recruits and subsequently oligomerizes the caspase-1-activating adaptor protein ASC, which activates caspase-1, leading to production of the mature cytokines interleukin 18 (IL-18) and IL-1β and subsequent cell death [@R3], [@R7], [@R8].

Despite these recent advances in our understanding of how cytoplasmic DNA is recognized by the AIM2 inflammasome, little is known about the precise role of the AIM2 inflammasome in the innate immune defense against intracellular microbial and viral pathogens. Of particular interest is the facultative intracellular gram-negative bacteria *Francisella tularensis*, the causative agent of tularemia. Invasion of the cytosol by *F. tularensis* leads to type I interferon production as well as activation of caspase-1 and cell death [@R9], [@R10]. *F. tularensis* activates the interferon response by a mechanism that is independent of signaling by plasma membrane or endosomal TLRs, or cytosolic RIG-I, MDA5, NOD1 or NOD2, but requires IRF3 signaling [@R10], [@R11]. It has been proposed that the host cell may sense cytosolic *F. tularensis* DNA via unidentified cytosolic DNA sensors leading to induction of type I interferons as well as activation of caspase-1 and cell death pathways during *F. tularensis* infection [@R10], [@R11].

We describe here the generation of AIM2-deficient mice to investigate whether AIM2 plays an important role in the host proinflammatory innate immune response to *F. tularensis* specifically, and to cytosolic DNA in general. Our results show that AIM2-deficient macrophages are defective in caspase-1 activation, IL-1β secretion and cell death in response to cytosolic DNA, or infection with *F. tularensis*. Although the AIM2 deficiency does not affect the transcriptional type I interferon response to *F. tularensis* infection, AIM2-deficient mice are more susceptible to the lethal effect of *F. tularensis* than wild-type mice. Our results thus suggest that the type I interferon response is not sufficient on its own for protection against *F. tularensis* infection and that the AIM2 inflammasome activity is required for full innate immunity against this pathogen. Our work also indicates that among all known PRRs, AIM2 is uniquely required for the pro-inflammatory innate immune response to *F. tularensis*.

RESULTS {#S1}
=======

AIM2 is important for caspase-1 activation by DNA {#S2}
-------------------------------------------------

To investigate the precise role of AIM2 in the host innate immune defense against dangerous cytosolic DNA produced by intracellular viral and microbial pathogens, we generated AIM2-deficient mice using the gene trap technology ([Supplementary Fig. 1a,b](#SD1){ref-type="supplementary-material"}) [@R12], [@R13]. Immunoblot analysis of spleen and bone marrow samples from an *Aim2*^−/−^ mouse and its *Aim2*^+/+^ littermate revealed the presence of full length AIM2 protein in the *Aim2*^+/+^ mouse but not in the *Aim2*^−/−^ littermate ([Fig. 1a](#F1){ref-type="fig"}, upper panels), indicating that the insertion of the gene trap vector in the *Aim2* gene resulted in disruption of *Aim2*. Heterozygous *Aim2*^+/−^ mice expressed reduced amount of AIM2 in the spleen compared to *Aim2*^+/+^ mice ([Fig. 1a](#F1){ref-type="fig"}, lower panels), indicating that the expression of AIM2 is gene-dose dependent. All *Aim2*^−/−^ mice had no obvious phenotypic abnormalities and were morphologically indistinguishable from their heterozygous or WT littermates ([Supplementary Fig. 1c](#SD1){ref-type="supplementary-material"}), indicating that AIM2 deficiency does not have any apparent adverse effects on mouse development.

*In vitro* studies with bone marrow-derived macrophages (BMDM) from *Aim2*^−/−^ and *Aim2*^+/+^ littermates revealed that liposome-delivered DNA activated caspase-1 and induced cell death in wild-type *Aim2*^+/+^, but not in *Aim2*^−/−^ BMDM ([Fig. 1b, c](#F1){ref-type="fig"}), indicating that AIM2 is indeed critical for sensing cytoplasmic DNA and activation of caspase-1. The AIM2 deficiency had no effect on caspase-1 activation by the Nlrp3 stimuli LPS plus ATP or LPS plus nigericin [@R14], or the Nlrp1 stimulus anthrax lethal factor [@R15] ([Fig. 1b](#F1){ref-type="fig"} and [Supplementary Fig. 2 a, b](#SD1){ref-type="supplementary-material"}). Reconstitution of the *Aim2*^−/−^ macrophages with a GFP-tagged AIM2 using retroviral transduction restored their responsiveness to transfected Cy3-labeled DNA as evidenced by oligomerization of the AIM2-GFP and the induction of pyroptotic cell death, which is dependent on caspase-1 activation ([Supplementary Fig. 3a](#SD1){ref-type="supplementary-material"}). There was no morphological evidence of pyroptotic cell death in the *Aim2*^−/−^ macrophages expressing GFP alone ([Supplementary Fig. 3b](#SD1){ref-type="supplementary-material"}).

Next we investigated the role of AIM2 in the innate immunity of macrophages against cytosolic DNA produced by infection with Vaccinia virus. In contrast to wild-type *Aim2*^+/+^ BMDMs, caspase-1 processing was completely absent in *Aim2*^−/−^ BMDMs ([Fig. 1d](#F1){ref-type="fig"}) 18 h post-infection with Vaccinia virus, providing definitive proof that the AIM2 inflammasome is indeed critical for detection of Vaccinia virus infection, as demonstrated previously by siRNA knockdown experiments [@R4].

AIM2 is important for caspase-1 activation by *Francisella* {#S3}
-----------------------------------------------------------

*F. tularensis* is a highly infectious bacterium that replicates in the cytoplasm of infected cells[@R16], [@R17], leading to the activation of an IRF3-dependent and TLR-independent type I interferon response, as well as a Nlrp3-independent, but ASC-dependent inflammasome, that causes cell death [@R9], [@R10]. These observations suggest that cytosolic DNA produced by *Francisella* during its escape from the phagosome might be the common ligand that activates both the type I interferon response, and possibly the AIM2 inflammasome pathways. To test this possibility, we analyzed inflammasome activation, and cell death by LDH release in macrophages from wild-type and *Aim2*^−/−^ mice after infection with *F. tularensis* subspecies *novicida* (*F. novicida*). Indeed, processing of caspase-1, secretion of IL-1β, and LDH release were completely absent in *Aim2*^−/−^ macrophages in response to *F. novicida* infection at 6 h post infection ([Fig. 2a,b](#F2){ref-type="fig"}), even at high multiplicity of infection ([Fig. 2a](#F2){ref-type="fig"}, 6^th^ & 7^th^ lane). Processing of caspase-1 and secretion of IL-1β were also absent in *Aim2*^−/−^ macrophages at 24 h post infection, although there was LDH release at this time point ([Supplementary Fig. 4a,b](#SD1){ref-type="supplementary-material"}) likely due to caspase-1-independent cell death as previously reported in *casp-1*^−/−^ macrophages [@R11]. In contrast, normal processing of caspase-1, secretion of IL-1β, and LDH release were seen in wild-type macrophages ([Fig. 2a,b](#F2){ref-type="fig"}, and [Supplementary Fig. 4a,b](#SD1){ref-type="supplementary-material"}). Processing of caspase-1 in response to *Francisella* infection or transfected DNA was also unimpaired in heterozygous *Aim2*^+/−^ macrophages, although it was reduced compared to wild-type macrophages due to the reduced level of AIM2 in the *Aim2*^+/−^ macrophages ([supplementary Fig. 5a,b](#SD1){ref-type="supplementary-material"}). Consistent with a critical role for AIM2 in the pyroptotic cell death pathway, morphological features of pyroptosis, including plasma membrane swelling and nuclear condensation, were very obvious in *F. novicida*-infected *Aim2*^+/+^, but not in *Aim2*^−/−^ macrophages ([Fig. 2c](#F2){ref-type="fig"}). Infection with *Salmonella typhimurium* which specifically activates the NLRC4 (Ipaf) inflammasome [@R18], resulted in normal processing of caspase-1 in both wild-type and *Aim2*^−/−^ macrophages ([Supplementary Fig. 4c](#SD1){ref-type="supplementary-material"}), indicating that AIM2 is not involved in the pro-inflammatory response to *Salmonella* infection. Consistent with previous findings [@R10], the activation of caspase-1 by *Francisella* infection was dependent on ASC but not on Nlrp3 ([Fig. 2d](#F2){ref-type="fig"}). Taken together, our results indicate that AIM2 is critical for the pro-inflammatory and cell death responses to *Francisella* infection, but dispensable for these processes in response to *S. typhimurium* infection.

The familial Mediterranean fever protein pyrin, which can also form an inflammasome complex with ASC and caspase-1 [@R19], [@R20], might be involved in caspase-1 activation by *F. novicida* in human macrophages [@R21]. To test this possibility in mouse macrophages, we infected peritoneal macrophages derived from wild-type or pyrin-deficient (*Mefv*^−/−^) mice [@R22] with *F. novicida* or stimulated them with the Nlrp3 stimulus, LPS plus nigericin ([Fig. 2e,f](#F2){ref-type="fig"}). Despite the notable upregulation of pyrin protein in the wild-type macrophages by these stimuli (2^nd^ to 4^th^ lanes, 4^th^ panel from top), there was no notable difference in processing of caspase-1, secretion of IL-1β, or LDH release between the wild-type and *Mefv*^−/−^ macrophages. These results indicate that pyrin does not play a role in the pro-inflammatory and cell death responses to *Francisella* infection in mice, or negatively regulate the activity of ASC or the inflammasome as previously proposed [@R22]--[@R24].

Mechanism of Activation of AIM2 by *Francisella* {#S4}
------------------------------------------------

Engagement of AIM2 by cytoplasmic DNA leads to formation of the oligomeric ASC pyroptosome, which induces pyroptotic cell death by activating caspase-1 [@R3], [@R8]. To investigate whether *Francisella* infection induces AIM2-dependent formation of the ASC pyroptosome, we analyzed the presence of oligomeric ASC in cell pellets of *Francisella*-infected wild-type and *Aim2*^−/−^ macrophages. As expected, *Francisella*-infection induced ASC pyroptosome formation in wild-type but not *Aim2*^−/−^ macrophages ([Fig. 3a](#F3){ref-type="fig"}, 3^rd^ lane). Similarly, liposome-delivered cytoplasmic DNA induced ASC pyroptosome formation in wild-type but not *Aim2*^−/−^ macrophages ([Fig. 3a](#F3){ref-type="fig"}, 2^nd^ lane). In contrast, LPS plus nigericin, which activates the Nlrp3 inflammasome, induced ASC pyroptosome formation in both wild-type and *Aim2*^−/−^ macrophages ([Fig. 3a](#F3){ref-type="fig"}, 4^th^ and 8^th^ lanes). Collectively, our data indicate that *Francisella*-infection induces pyroptotic cell death via AIM2-mediated ASC pyroptosome formation.

To gain further insight into the signaling pathway by which *Francisella* infection activates the AIM2 inflammasome, we investigated the role of cytoplasmic potassium efflux, which is critical for formation of the ASC pyroptosome and recruitment of caspase-1 to ASC oligomers [@R8]. Inhibition of potassium efflux by increasing potassium concentration in the culture medium completely blocked ASC pyroptosome formation, caspase-1 activation and IL-1β secretion by *Francisella*-infection ([Fig. 3b](#F3){ref-type="fig"}), indicating that depletion of intracellular potassium is required for assembly of the AIM2 inflammasome and formation of the ASC pyroptosome. Activation of caspase-1 and cell death by *Francisella*-infection was markedly blocked by the actin oligomerization inhibitor cytochalasin D, and the endosomal acidification inhibitors bafilomycin A or NH~4~Cl ([Fig. 3c--f](#F3){ref-type="fig"}), indicating that bacterial internalization and lysosomal acidification are required for recognition of *Francisella*-infection and activation of the AIM2 inflammasome. Inhibition of *Francisella*-induced caspase-1 activation by bafilomycin was not due to inhibition of bacterial uptake or replication as more intracellular bacteria were found in bafilomycin treated cells compared to the untreated control at 3 h post infection ([supplementary Fig. 6](#SD1){ref-type="supplementary-material"}). The increased bacterial count in bafilomycin treated cells is consistent with previous observations linking phagosomal acidification to killing and degradation of phagocytosed bacteria [@R25].

IRF3 is important for AIM2 activation by *Francisella* {#S5}
------------------------------------------------------

Activation of the inflammasome by *Francisella* infection requires an intact type I interferon response for efficient inflammasome activation [@R10]. Consistent with these studies, *Francisella* infection of *Irf3*^−/−^ macrophages, which are defective in the secretion of type I interferons in response to cytosolic DNA, resulted in less efficient activation of the AIM2 inflammasome compared with wild-type macrophages ([Fig. 4a](#F4){ref-type="fig"}, left panels). In contrast, liposome-delivered DNA induced similar activation of the AIM2 inflammasome in both WT and *Irf3*^−/−^ macrophages ([Fig. 4a](#F4){ref-type="fig"}, right panels). Similar expression levels of AIM2 in wild-type and *Irf3*^−/−^ macrophages ([Fig. 4a](#F4){ref-type="fig"}, lower panel), were observed ruling out the possibility that *Irf3*^−/−^ macrophages express less AIM2. To determine if type I interferon signaling through its IFNAR1 could restore AIM2 activation by *Francisella* infection in the *Irf3*^−/−^ macrophages, we treated these macrophages with IFN-β at the time of infection and assayed caspase-1 activation at 6 h post-infection. Simultaneous treatment of *Irf3*^−/−^ macrophages with both IFN-β and *F. novicida* restored *Francisella*--induced caspase-1 activation in these cells ([Fig. 4b](#F4){ref-type="fig"}, right panels). Concomitant treatment with IFN-β at the time of infection slightly enhanced *Francisella*--induced caspase-1 activation in WT *Irf3*^+/+^ macrophages ([Fig. 4b](#F4){ref-type="fig"}, left panels). Restoration of *Francisella*--induced caspase-1 activation in *Irf3*^−/−^ macrophages required concurrent treatment with IFNβ and *Francisella*, as no restoration was observed if IFN-β treatment was done 2 h post-infection ([supplementary Fig. 7a](#SD1){ref-type="supplementary-material"}, left panels). No activation of caspase-1 was observed by IFN-β treatment alone ([supplementary Fig. 7a](#SD1){ref-type="supplementary-material"}, right panel). Additionally, concurrent treatment of *Aim2*^−/−^ macrophages with IFN-β and *Francisella* did not restore *Francisella*--induced caspase-1 activation in these cells ([supplementary Fig. 7b](#SD1){ref-type="supplementary-material"}), indicating that IFN-β is not sufficient for *Francisella*-induced caspase-1 activation in the absence of AIM2.

To further investigate the role of type I interferons in the mechanism of activation of AIM2 by *Francisella* infection, we primed wild-type and *Irf3*^−/−^ macrophages with IFN-β 2 h prior to infection with *Francisella*, and measured caspase-1 activation at different time points post-infection ([supplementary Fig. 8](#SD1){ref-type="supplementary-material"}). In the absence of IFN-β priming, caspase-1 processing in wild-type macrophages was barely detectable at 3 h post-infection. In contrast, maximum caspase-1 processing was observed at 3 h post infection in IFN-β-primed wild-type macrophages. Although un-primed *Irf3*^−/−^ macrophages showed less efficient caspase-1 activation than wild-type macrophages at 3 and 5 h post-infection, they showed comparable caspase-1 activation to wild-type macrophages following IFN-β-priming. These results indicate that priming of macrophages with IFN-β accelerates and enhances the activation of the AIM2 inflammasome by *Francisella* infection not only in IRF3-deficient macrophages, but also in wild-type macrophages. These results also suggest that the delay in caspase-1 activation observed in un-primed WT macrophages might be due to the lack of type I interferons in the initial stages of *Francisella* infection.

Like IRF3-deficient macrophages, IFNAR1-deficient macrophages are also defective in activation of caspase-1 in response to *Francisella* infection (ref [@R10] and [Fig. 4c](#F4){ref-type="fig"}). However, this defect cannot be corrected by IFN-β-priming indicating that signaling by IFNAR1 is required for efficient activation of the AIM2 inflammasome by *Francisella* infection.

The impaired AIM2 inflammasome activation in *Ifnar1*^−/−^ macrophages was not caused by a lack of intracellular bacterial replication. On the contrary, the number of intracellular *Francisella* in *Ifnar1*^−/−^ macrophages was notably higher than in wild-type macrophages at 5 h post-infection and reached to almost 50 fold higher at 24 h post infection ([Supplementary Fig. 9](#SD1){ref-type="supplementary-material"}). These results are consistent with a previous report[@R10]. Collectively these observations indicate that type I interferon signaling acts upstream of the AIM2 inflammasome, perhaps to enhance killing and lysis of *Francisella* in the phagosome to generate the cytosolic DNA that activates the AIM2 inflammasome (see model in [supplementary Fig. 10](#SD1){ref-type="supplementary-material"}, and discussion for details).

AIM2 is not critical for type I interferon production {#S6}
-----------------------------------------------------

To rule out the possibility that defective activation of the inflammasome in *Aim2*^−/−^ macrophages is due to defective type I interferon production or signaling, we quantitated the amounts of secreted IFN-β in culture media of wild-type and *Aim2*^−/−^ macrophages infected with *F. novicida*, and also determined the status of STAT-1 phosphorylation in lysates from these cells ([Fig. 4d,e](#F4){ref-type="fig"}). Our results show that IFN-β production from *Aim2*^−/−^ macrophages is actually higher than from wild-type macrophages in response to *Francisella* infection ([Fig. 4d](#F4){ref-type="fig"}). However, there was no significant difference in STAT-1 phosphorylation between *Francisella*-infected wild-type and *Aim2*^−/−^ macrophages ([Fig. 4e](#F4){ref-type="fig"}). These results indicate that AIM2 is not critical for type I interferon production or signaling and that AIM2 deficiency does not negatively impact type I interferon response to *F. novicida* infection. In fact, AIM2 deficiency appears to enhance IFN-β production in response to *F. novicida* infection. This result is consistent with recent observations that siRNA-mediated knockdown of AIM2 potentiate IFN-β production in response to transfected cytosolic DNA [@R4]. The production of IFN-β induced by *Francisella*-infection was completely blocked by bafilomycin A ([Fig. 4f](#F4){ref-type="fig"}), indicating that lysosomal acidification is not only required for activation of the AIM2 inflammasome, but also necessary for *Francisella*-induced type I interferon production.

Francisella DNA induces AIM2 oligomerization {#S7}
--------------------------------------------

Cytoplasmic DNA activates AIM2 by directly binding to its HIN-200 domain leading to its oligomerization. This process can be visualized in live cells expressing a GFP-tagged AIM2 and a Cy3-labeled DNA ([Fig. 5a](#F5){ref-type="fig"} and ref [@R3]). Notably, the cytosolic DNA that is bound to AIM2 in the oligomeric AIM2-DNA complex can also be visualized with the DNA-specific Hoechst 33342 fluorescent stain ([Fig. 5a](#F5){ref-type="fig"}). To formally demonstrate that AIM2 senses cytosolic DNA produced by *Francisella* infection, we infected the *Nlrp3*^−/−^-AIM2-GFP-N1 macrophages (a *Nlrp3*^−/−^ cell line stably expressing a C-terminal GFP-tagged AIM2) [@R3] with *F. novicida* and subsequently stained the infected cells with Hoechst stain. The *Nlrp3*^−/−^ AIM2-GFP-N1 macrophages were used in these experiments to rule out the involvement of Nlrp3 in the response to cytosolic DNA or *Francisella* infection. AIM2 was evenly distributed in the cytoplasm and nuclei of the uninfected cells ([Fig. 5b](#F5){ref-type="fig"}, upper panels). Infection of these cells with *F. novicida* resulted in AIM2 oligomerization ([Fig 5b](#F5){ref-type="fig"}, lower panels, and [supplementary Fig. 11](#SD1){ref-type="supplementary-material"}) as evidenced by the clustering of the AIM2-GFP. These AIM2-GFP clusters were also visible with the vital DNA-specific Hoechst stain indicating that AIM2 is clustered by binding to cytosolic DNA. The infected macrophages that contained the AIM2-DNA clusters showed clear features of pyroptotic cell death.

To provide direct evidence that the cytosolic DNA responsible for clustering of AIM2-GFP in these cells is derived from *Francisella*, we labeled *Francisella* DNA with Hoechst stain by pre-staining *F. novicida* with Hoechst stain prior to using them to infect the *Nlrp3*^−/−^ AIM2-GFP-N1 macrophages. As expected, infection of these cells with the Hoechst-labeled *Francisella* resulted in clustering of AIM2-GFP around the Hoechst-labeled DNA ([Fig. 5c](#F5){ref-type="fig"}, lower panels, and [supplementary Fig. 11b](#SD1){ref-type="supplementary-material"}). Because only *Francisella* DNA is labeled with Hoechst stain, these results provide direct evidence that *Francisella* DNA is responsible for oligomerizing AIM2. Collectively, our results indicate that *F. novicida* infection of macrophages generates cytosolic DNA that specifically binds to and induces AIM2 oligomerization leading to the activation of caspase-1 and cell death (see model in [Supplementary Fig. 10](#SD1){ref-type="supplementary-material"}).

Innate immunity against *Francisella* infection requires AIM2 {#S8}
-------------------------------------------------------------

The above results indicate that AIM2 is important for the pro-inflammatory and cell death responses to *Francisella*-infection *in vitro*, through a mechanism that involves the recognition of cytoplasmic DNA produced by this intracellular pathogen. To assess the precise role of AIM2 in the host innate immune defense against *Francisella*-infection, wild-type and *Aim2*^−/−^ mice were challenged subcutaneously with live *F. novicida*. Compared to wild-type mice, the subcutaneous infection of *Aim2*^−/−^ mice with *F. novicida* resulted in dramatically higher rate of mortality ([Fig. 6a](#F6){ref-type="fig"}). The mortality rate of *Aim2*^−/−^ mice on day 5 was 100% compared with just 33% in wild-type mice. The remaining wild-type mice survived beyond 20 days post infection. Consistent with these results, the bacterial burdens in tissues of *Aim2*^−/−^ mice were markedly higher than those in wild-type mice 48 h post infection ([Fig. 6b](#F6){ref-type="fig"}). These results indicate that the AIM2 inflammasome plays a crucial role in the host defense against *Francisella*-infection likely by decreasing bacterial burden in tissues, thereby preventing systemic infection. Consistent with the critical role of AIM2 in the production of caspase-1-generated cytokines, the serum concentration of IL-18 was much higher in wild-type mice compared to *Aim2*^−/−^ mice, 24 h post-infection ([Fig. 6b](#F6){ref-type="fig"}) Taken together, these results indicate that the lack of AIM2 inflammasome activity increases the virulence of *Francisella* in mice due to defective caspase-1 activation, which is critical for the production of the caspase-1-generated cytokines such as IL-1β and IL-18, and induction of pyroptotic cell death of the infected macrophages.

DISCUSSION {#S9}
==========

Recent biochemical evidence has implicated AIM2 in the recognition of, and innate immune response to cytosolic DNA [@R3]--[@R6]. Recognition of cytosolic DNA by AIM2 activates the non-transcriptional inflammatory caspase-1 pathway in macrophages, leading to production of the potent inflammatory cytokines, IL-1β and IL-18, and cell death. We now provide genetic evidence that AIM2 is a critical PRR uniquely involved in the recognition and innate immune defense against infection with the potentially lethal intracellular pathogen *Francisella tularensis*.

Several proteins of the NLR family are involved in the activation of the inflammatory caspase-1 pathway in macrophages in response to pathogenic infection or products [@R26]--[@R28]. For example, NLRC4 (also called Ipaf) is a PRR involved in detection of intracellular infection with *Salmonella* and activation of the caspase-1 pathway in response to this pathogen [@R18]. *Salmonella* flagellin is the suggested molecular component responsible for activation of NLRC4 [@R29], [@R30]. Another PRR, Nlrp1, is involved in activation of caspase-1 in response to stimulation with anthrax lethal toxin [@R15]. In contrast, the NLR protein Nlrp3 (also called Nlrp3/cryopyrin) is involved in caspase-1 activation following infection with a broad range of bacterial, viral, or fungal pathogens, and in response to different stress stimuli [@R28], [@R31]. Nevertheless, the mechanism by which Nlrp3 recognizes such a broad range of pathogens and stimuli is still unclear.

None of the above mentioned NLRs or other known NLRs, however, are involved in sensing *Francisella* infection. Although macrophages from AIM2-deficient mice are not defective in sensing NLRC4, Nlrp1 and Nlrp3 stimuli, as evidenced by their normal caspase-1 activation response to *Salmonella*, anthrax lethal toxin, or LPS plus ATP or nigericin, or MSU, they are clearly unable to activate caspase-1 in response to *Francisella* infection. This suggests that *Francisella* may have developed mechanisms to evade detection of their non-nucleic acid PAMPs by the host cell inflammasome components such as NLRC4, Nlrp1 or Nlrp3 and probably by other as yet uncharactarized inflammasomes. Nevertheless, several studies suggest that *Francisella* infection activates TLR2 signaling via MyD88 leading to NF-κB-dependent transcriptional induction of pro-inflammatory cytokines [@R32]--[@R34]. However, this response does not appear to be sufficient for activation of the Nlrp3 inflammasome because *Aim2*^−/−^ macrophages are completely defective in caspase-1 activation in response to infection with *Francisella*.

Phagosomal disruption occurs during the escape of *Francisella* from the phagosome into the cytosol [@R35]--[@R37]. This may be necessary for activation of caspase-1 and type I interferon production by *Francisella* because mutant strains that cannot disrupt the phagosome and escape into the cytosol are unable to induce type I interferons or activate caspase-1 [@R10], [@R38]. Despite previous observations of Nlrp3 inflammasome activation by phagosomal disruption [@R26], [@R39], [@R40], it is intriguing that phagosomal disruption during *Francisella* escape does not lead to Nlrp3 inflammasome activation as evidenced by the absence of caspase-1 activation in *Francisella*-infected AIM2-deficient macrophages. This defect in caspase-1 activation cannot be attributed to a defect in Nlrp3 signaling because these macrophages have normal amounts of caspase-1 activation in response to specific Nlrp3 stimuli such as LPS plus ATP or the pore forming toxin nigericin. Additionally, this defect is not likely due to a specific defect in *Francisella*-induced phagosomal disruption since infection of the AIM2-deficient macrophages with *Francisella* leads to even higher type I interferon production than that seen in wild-type macrophages, indicating normal phagosomal disruption and escape. Altogether, these observations suggest that phagosomal disruption generally does not induce Nlrp3 inflammasome activation and it is likely that a more specific stimulus or additional stimuli are required. Alternatively, *Francisella* might possess means to inhibit Nlrp3 inflammasome activation during its escape from the phagosome.

AIM2 inflammasome activation requires direct interaction of AIM2 with DNA [@R3]. This interaction leads to oligomerization of AIM2 and the formation of a large AIM2-DNA complex visible by confocal microscopy [@R3]. Our results show that infection of macrophages with *Francisella* also induces formation of a large AIM2-DNA complex, indicating that *Francisella* infection delivers DNA into the cytosol that is then recognized by AIM2. The exact mechanism by which *Francisella* delivers its DNA into the cytosol is currently unclear. Nevertheless, our results suggest that the DNA which activates AIM2, and likely type I interferon signaling, is produced by breakdown and digestion of killed *Francisella* by phagosomal enzymes. Supporting this conclusion, bafilomycin which can prevent killing and degradation of bacteria in the phagosome by inhibiting the activity of vacuolar-type ATPases that mediate lumen acidification [@R25], [@R41], completely inhibited AIM2 inflammasome activation and IFN-β production in wild-type macrophages by *Francisella* infection. Considering that bafilomycin does not prevent *Francisella* phagosomal permeabilization and escape into the cytosol [@R35], phagosomal escape by live *Francisella* and its replication in the cytosol is likely not the signal that activates AIM2 or type I interferon response. Rather killing and degradation of *Francisella* and the subsequent phagosomal disruption triggered by live *Francisella* escape is probably responsible for delivering *Francisella* DNA into the cytosol for recognition by AIM2 and type I interferon-signaling pathways. As a consequence we expect that more virulent strains of *Francisella* such as *F. tularensis* subsp. *tularensis*, which infects humans must have evolved mechanisms that protect them from phagosomal lysis, perhaps by altering the rate of acidification and maturation of their phagosomes [@R36]. Therefore, these strains will be less efficiently detected by AIM2 due to decreased phagosomal release of killed bacterial DNA into the cytosol, and thereby would have a better chance of intracellular replication and an increased ability to cause a systemic infection.

IFN-β signaling through its IFNAR1 receptor is required for efficient caspase-1 activation by *Francisella* [@R10], [@R26]. IFNAR1- or IRF3-deficient macrophages, which exhibit impaired IFN-β production, showed less efficient caspase-1 activation by *Francisella* compared to wild-type macrophages[@R10], [@R26]. Our data show that the reduced caspase-1 activation by *Francisella* in *Irf3*^−/−^ or *ifnar1*^−/−^ macrophages is not due to decreased AIM2 expression because these macrophages express comparable amounts of AIM2 as wild-type macrophages. Additionally, *Irf3*^−/−^ and *ifnar1*^−/−^ [@R42] macrophages exhibit normal caspase-1 activation in response to transfected DNA, ruling out the possibility that IFN-β signaling is required for transcriptional induction of a host factor critical for caspase-1 activation by the AIM2 inflammasome. Although both *Francisella* and transfected DNA both activate the AIM2 inflammasome IFN-β signaling might be required for efficient killing of *Francisella* in the phagosome and/or phagosomal permeablization and release of *Francisella* DNA into the cytosol. Indeed, *ifnar1*^−/−^ macrophages harbor more bacteria 5--24h post-infection compared to wild-type macrophages, likely due to defective phagosomal bactericidal activity of the *ifnar1*^−/−^ macrophages. Consequently, these macrophages might produce less cytosolic DNA, which could provide a rationale for the observed defective AIM2 inflammasome activation in these macrophages.

Based on current information on the life cycle of *Francisella* in macrophages [@R10], [@R26], [@R43], and our own data, we propose a two step mechanism by which *Francisella* infection of macrophages activates the AIM2 inflammasome. Shortly after *Francisella* enters the phagosome, the phagosome is rapidly acidified [@R17]. Acidification causes lysis of some of the ingested bacteria and release of bacterial DNA into the lumen of the phagosome. During phagosomal escape of live *Francisella*, which occurs as early as 1 h post-infection [@R16], [@R17], the phagosome is ruptured releasing both live *Francisella* and undigested DNA of killed *Francisella* into the cytosol. This amount of cytosolic DNA might not be sufficient for AIM2 activation, but is likely sufficient for activation of an as yet unknown DNA sensor, which in turn activates IRF3 leading to production of type I interferons such as IFN-β. Bafilomycin treatment completely inhibited *Francisella*-induced IFN-β production, supporting this scenario. IFN-β binds to IFNAR1 resulting in the activation of this signaling pathway. This initial IFN-β signaling process acts like a positive feedback loop perhaps to increase phagosomal acidification and/or the bactericidal activity of the phagosomal enzymes thereby enhancing the release of more killed *Francisella* DNA into the cytosol. This is supported by the observations that prior priming of wild-type or *Irf3*^−/−^ macrophages before infection with *Francisella*, or infection of these macrophages with *Francisella* together with IFN-β co-treatment accelerates and enhances AIM2 inflammasome activation, whereas inhibiting phagosomal acidification markedly reduces AIM2 inflammasome activation. In the second step of this process, the increased concentration of cytosolic DNA, as a result of IFN-β-induced phagosomal disruption, leads to full AIM2 activation by inducing its oligomerization. The oligomerized AIM2-DNA complex serves as a molecular platform to recruit ASC and facilitate its oligomerization into the large "ASC pyroptosome" [@R8]. Consistently, *Francisella* infection or transfection with cytosolic DNA induces ASC pyroptosome formation in wild-type but not *Aim2*^−/−^ macrophages, and can be completely blocked by \~120--180 mM extracellular KCl. It is likely that the ASC pyroptosome then activates procaspase-1 as described before [@R8], leading to pyroptotic cell death and production of the pro-inflammatory cytokines IL-1β and IL-18.

The phenotype of *Francisella*-challenged *Aim2*^−/−^ provides further support that AIM2 is critical for sensing *Francisella* infection and activation of the ASC-caspase-1 pathway, not only in isolated macrophages, but also in a whole animal model. Indeed this phenotype is reminiscent of the phenotype seen in *Francisella*-challenged *Casp-1*^−/−^ or *A*sc^−/−^ (*Pycard*^−/−^) mice [@R9]. In these mice strains as well as in *Aim2*^−/−^ mice, *Francisella* infection is associated with increased lethality due to increased bacterial burden and systemic infection [@R9]. The increased in bacterial burden in these mice is most likely due to decreased cell death of *Francisella*-infected macrophage, and decreased pro-inflammatory cytokine production. *Francisella*-induced macrophage cell death shares features of pyroptotic cell death induced by other pathogenic bacteria [@R9]. However, *Francisella*-induced macrophage cell death is clearly dependent on AIM2, as well as on caspase-1 and ASC [@R9] providing further proof that AIM2, ASC and caspase-1 function in the same signaling pathway that recognizes *Francisella* infection.

In conclusion our data provides clear genetic and biochemical evidence that activation of the AIM2 inflammasome represents a crucial innate immune defense against *Francisella* infection. Future studies with the AIM2-deficient mice should clarify its role in the innate immune response to other intracellular microbial and viral pathogens as well as its involvement in nucleic acid-dependant autoimmune diseases such as systemic lupus erythematosus.

METHODS {#S10}
=======

Generation of AIM2 deficient mice {#S11}
---------------------------------

AIM2-deficient mice were generated by the gene trap method [@R13], from an ES cell clone obtained from the International Gene Trap Consortium [@R12]. All mice were used in experiments following protocols approved by Institutional Animal Care and Use Committee, Thomas Jefferson University. See (**Supplementary methods**) for details.

Antibodies and reagents {#S12}
-----------------------

The polyclonal anti-AIM2 antibody was raised in rabbits (Invitrogen) against a mixture of recombinant mouse and human AIM2 proteins prepared in Alnemri laboratory. This antibody can detect endogenous mouse and human AIM2 proteins. The polyclonal anti-mouse pyrin was raised in rabbits (Invitrogen) against a truncated recombinant mouse pyrin protein (residues 1--349) prepared in our lab. The anti-IL-1β monoclonal antibody (3ZD) was obtained from the NCI preclinical repository, Biological resource branch. Other antibodies used against mouse Nlrp3 (polyclonal anti-Nlrp3 PYD; our lab), mouse ASC (polyclonal anti-mouse ASC; from Dr. Junji Sagara), and mouse caspase-1 p20 (monoclonal anti-mouse caspase-1 p20; from Dr. Junying Yuan) were described before [@R8], [@R20], [@R31]. Antibody to STAT1 phosphorylated at Tyr701 (9171S) and antibody to mouse STAT1 (9172) were from Cell Signaling. ATP, nigericin, Poly (dA:dT) sodium salt, Bafilomycin A, and cytochalasin D were from Sigma-Aldrich. Ultrapure LPS was from Invivogen. Anthrax lethal factor and protective antigen were from List Biological Labs. Disuccinimidyl suberate (DSS) was from Thermo Fisher Scientific. CytoTox96 LDH-release kit was from Promega.

Macrophage cell culture and stimulation {#S13}
---------------------------------------

Mouse bone marrow cells were isolated from mouse femurs with sterile Dulbecco modified Eagle medium (DMEM) and cultured in 6-well plates for 5 to 7 days in DMEM (GIBCO) supplemented with 10% L929 cell conditioned medium, 10% fetal bovine serum (FBS), and 1% penicillin-streptomycin. Infection of macrophages with Vaccinia virus (WR strain) were at the indicated MOI for 18 h. In some experiments, differentiated macrophages were treated with or without ultrapure LPS (500 ng/ml) in serum-free OPTI-MEM^®^ I medium for 5 h followed by ATP (5 mM) or nigericin (2.5 µM) as indicated. Anthrax lethal toxin (protective antigen and lethal factor) treatment of macrophages were carried out at 5 µg/ml.

Infection of macrophages with *F. novicida* {#S14}
-------------------------------------------

Wildtype *F. tularensis* subspecies *novicida* (U112) was obtained from Dr. Denise M. Monack (Stanford University) and grown overnight with shaking in tryptic soy broth (Difco Laboratories) supplemented with 0.2% cysteine as described before [@R10]. To determine the effect of AIM2 deficiency on *F. novicida*-induced caspase-1 activation, *Aim2*^−/−^ and *Aim2*^+/+^ macrophages were seeded in 6-well plates at a density of 2 × 10^6^ cells/well in OPTI-MEM^®^ I serum free medium and allowed to attach for 2 hours. The cells were infected with different MOIs of *F. novicida* in 2 ml of OPTI-MEM^®^ I medium for 6 hours as described before [@R10]. The culture supernatants and cells were separated and then processed for immunoblot analysis as described below. In the experiments involving IFNβ priming, cells were pretreated with 250 U/mL of mouse IFN-β 2 h before infection. Cells were then infected with *F. novicida*. After 1 h, gentamycin (100 µg/mL) were added and incubated for 30 min. Cells were then washed with PBS and were further incubated in Opti-MEM containing a low concentration of gentamycin (2.5 µg/ml) for various periods of time until they were collected.

Immunoblot analysis {#S15}
-------------------

Proteins were precipitated from cell culture super¬natants by the addition of an equal volume of methanol and 0.25 volumes of chloroform as described [@R3], [@R40]. Samples were separated by 12.5 % SDS-PAGE and were transferred onto nitrocellulose membranes. Blots were probed with rat monoclonal-anti-mouse caspase-1 p20 antibody or anti-IL-1β monoclonal antibody (3ZD). Total cell lysates were mixed with SDS sample buffer, fractionated on 12.5 % SDS-PAGE and then immunoblotted with the appropriate antibodies as described above. Each immunoblot in each figure is a representative of at least 3 independent experiments.

Assay of ASC pyroptosome formation in macrophages {#S16}
-------------------------------------------------

These experiments were performed essentially as described recently [@R44], [@R45] and further described in (**Supplementary methods**).

Infection of mice with *F. novicida* {#S17}
------------------------------------

All mice were kept under specific pathogen-free conditions in filter-top cages at Thomas Jefferson University, and experimental studies were in accordance with the Institutional Animal Care and Use Guidelines. Mice were provided with sterile water and food *ad libitum*. Pairs of *Aim2*^−/−^ *and Aim2*^+/+^ littermates 8--10 weeks of age were inoculated with the indicated dose of strain U112 subcutaneously in a 0.05-ml vol. Each pair of AIM2^+/+^ and AIM2^−/−^ used in the experiment were siblings derived from the same parents. The mice were monitored for signs of distress/illness and lethality thrice daily for 3 weeks for the survival study. For determination of bacterial burden in mouse tissues, 6 pairs of *Aim2*^−/−^ *and Aim2*^+/+^ littermates (siblings) 10--12 weeks of age were inoculated with the indicated dose of strain U112 subcutaneously in a 0.05-ml vol. Spleen and liver were harvested 48 h post-infection, homogenized, and dilutions were plated on Cystine Heart Agar plates and incubated at 37° C for 24 h, and CFU were enumerated and expressed as CFU/g tissue.

LDH release assay {#S18}
-----------------

Cell culture supernatants and cell pellets from treated macrophages were collected at the end of treatment and assayed for LDH activity with the CytoTox96 LDH-release kit (Promega), as described by the manufacturer's protocols. Results are representative of at least 3 independent experiments.

Confocal microscopy {#S19}
-------------------

In the experiments using the Cy™3-labeled plasmid DNA, *Nlrp3*^−/−^-mAIM2-EGFP-N1 or *Aim2*^−/−^-mAIM2-EGFP-N1 macrophages were seeded on 35-mm glass-bottomed culture dishes (Mat Tek) and were allowed to attach for 24 h. Next day cells were transfected with Cy™3-labeled plasmid DNA (0.5 µg/dish) for 2--3 hours using Lipofectamine 2000 and then stained with Hoechst 33342 for 30 min. Cells were then observed using a Zeiss LSM 510 Meta confocal microscope at the Kimmel Cancer Center core facility. In the *Francisella* infection experiments, *Nlrp3*^−/−^-mAIM2-EGFP-N1 macrophages seeded on 35 mm cover glass bottom culture dishes were infected with un-stained or Hoechst-*stained F. novicida* (MOI 200:1) for 6 h. The un-stained *F. novicida*-infected cells were then stained with Hoechst 33342 stain, whereas the Hoechst-*stained F. novicida*-infected cells were not stained after infection. Cells were observed using a Zeiss LSM 510 Meta confocal microscope. The GFP (green) was excited with the 488 nm argon laser. The DNA Hoechst 33342 stain (blue) was excited with the 405 nm diode laser. The Cy™3 (red) was excited with the 543 nm He/Ne Laser. The *Nlrp3*^−/−^-mAIM2-EGFP-N1 and *Aim2*^−/−^-mAIM2-EGFP-N1 stable cell lines were generated by retroviral transduction, followed by sorting using Flow Cytometry at the Kimmel Cancer center core facility, as described before [@R3].

Supplementary Material {#SM}
======================

Note: [Supplementary information](#SD1){ref-type="supplementary-material"} is available on the Nature Immunology website.
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![Disruption of mouse *Aim2* abolishes activation of the inflammasome by cytoplasmic DNA and vaccinia virus. (**a**) Immunoblot analysis of the expression of AIM2 in spleens and BMDMs from *Aim2*^+/+^ and *Aim2*^−/−^ littermates (top) and in spleens from *Aim2*^−/−^, *Aim2*^+/+^ and *Aim2*^+/−^ mice (bottom), assessed with an antibody specific for mouse AIM2. β-actin serves as a loading control. (**b**) Immunoblot (IB) analysis of mouse procaspase-1, caspase-1 (p20 subunit) and/or AIM2 in culture supernatants (Sup) and lysates (Lys) of *Aim2*^+/+^ and *Aim2*^−/−^ BMDMs left untreated (None) or transfected with the synthetic DNA poly(dA:dT) or plasmid DNA (pcDNA), or treated for 5 h with LPS (500 ng/ml) followed by nigericin (2.5 µM) for 45 min (LPS + nig), assessed with monoclonal antibody to mouse caspase-1 p20 (anti-p20). (**c**) Release of LDH into culture supernatants of the BMDMs described in b, presented relative to the total cellular LDH content. \**P* \< 0.05 and \*\**P* \< 0.01, *Aim2*^+/+^ versus *Aim2*^−/−^ (Student's *t*-test). (**d**) Immunoblot analysis of mouse procaspase-1 and caspase-1 in culture supernatants and lysates of mouse *Aim2*^−/−^ and *Aim2*^+/+^ BMDMs infected for 18 h with vaccinia virus (multiplicity of infection (MOI), above lanes). Data are representative of at least three experiments (mean and s.d. in c).](nihms184297f1){#F1}

![AIM2 is required for *F. novicida*--induced activation of the inflammasome. (**a**) Immunoblot analysis of mouse procaspase-1, caspase-1, IL-1β, AIM2 and/or pro-IL-1β in culture supernatants and lysates of mouse *Aim2*^−/−^ and *Aim2*^+/+^ macrophages left untreated or infected for 6 h with *F. novicida* (FN; MOI in parentheses above lanes) or treated with LPS and nigericin as described in [Figure 1b](#F1){ref-type="fig"}. (**b**) Release of LDH into culture supernatants of the macrophages in a. \**P* \< 0.05, \*\**P* \< 0.01 and \*\*\**P* \< 0.005, *Aim2*^+/+^ versus *Aim2*^−/−^ (Student's *t*-test). (**c**) Confocal live-cell microsopy of *Aim2*^−/−^ and *Aim2*^+/+^ BMDMs left uninfected (UI) or infected for 6 h with *F. novicida*; nuclei were stained with Hoechst stain (blue). Images are merged differential interference contrast and Hoechst channels. Original magnification, x40. (**d**) Immunoblot analysis of mouse procaspase-1, caspase-1, ASC, AIM2 and/or Nlrp3 in culture supernatants and lysates of mouse wild-type, ASC-deficient (Pycard^−/−^; called 'Asc^−/−^' here) and Nlrp3^−/−^ macrophages infected with *F. novicida* for 6 h or for 24 h (far right; MOI in parentheses above lanes). (**e**) Immunoblot analysis of mouse procaspase-1, caspase-1, IL-1β, pyrin and/or pro-IL-1β in culture supernatants and lysates of mouse pyrin-deficient (*Mefv*^−/−^) and pyrin-sufficient (*Mefv*^+/+^) macrophages infected for 6 h with *F. novicida* (MOI in parentheses above lanes) or treated with LPS and nigericin as described in a. (**f**) Release of LDH into culture supernatants of the macrophages in e. Data are representative of at least three experiments (mean and s.d. in b,f).](nihms184297f2){#F2}

![Role of the ASC pyroptosome, potassium depletion, actin polymerization and lysosomal acidification in activation of the AIM2 inflammasome by *F. novicida*. (**a**) Immunoblot analysis of ASC pyroptosomes in *Aim2*^+/+^ and *Aim2*^−/−^ BMDMs transfected with poly(dA:dT), infected for 6 h with *F. novicida* (MOI, 500), or treated with LPS and nigericin as described in [Figure 1b](#F1){ref-type="fig"}; pellets of whole-cell lysates centrifuged at 3,800g followed by crosslinking with disuccinimidyl suberate (Pell), as well as cell lysates and culture supernatants, were hybridized with anti--mouse ASC, anti--mouse AIM2 and anti-caspase-1. (**b**) Immunoblot analysis of ASC pyroptosomes in *Aim2*^+/+^ BMDMs left uninfected or infected for 6 h with *F. novicida* (MOI, 500) in the presence of increasing concentrations of KCl in the culture medium, then fractionated and analyzed as in a. (**c,d**) Immunoblot analysis of mouse procaspase-1, caspase-1, AIM2 and/or pro-IL-1β in culture supernatants and lysates of *Aim2*^+/+^ BMDMs infected for 6 h with *F. novicida* (MOI, above lanes) in the presence (+ cytoD) or absence of cytochalasin D (**c**) or infected for 6 h with the *F. novicida* (MOI, 250) in the presence of vehicle (+ veh), bafilomycin (+ baf) or NH~4~Cl (+ AC; d). (**e,f**) Release of LDH into culture supernatants of the BMDMs in c (e) and d (f). (**e**) \**P* \< 0.001, with versus without cytochalasin D (Student's *t*-test); (**f**) \**P* \< 0.05, \*\**P* \< 0.01 and \*\*\**P* \< 0.001, *F. novicida* versus vehicle (Student's *t*-test). Data are representative of two (a--d) or three (e,f) experiments (mean and s.d. in e,f).](nihms184297f3){#F3}

![IRF3 signaling is required for activation of the AIM2 inflammasome by *F. novicida* but not by liposome-delivered DNA. (**a,b**) Immunoblot analysis of mouse procaspase-1, caspase-1 and/or AIM2 in culture supernatants and lysates of mouse *Irf3*^−/−^ and *Irf3*^+/+^ macrophages infected for 6 h with *F. novicida* (MOI, in parentheses above lanes), treated with LPS and nigericin as described in [Figure 1b](#F1){ref-type="fig"}, or transfected with poly(dA:dT) (**a**), or infected with *F. novicida* (MOI, 250) in the presence or absence of IFN-β (**b**). (**c**) Immunoblot analysis of mouse procaspase-1, caspase-1 and/or AIM2 in culture supernatants and lysates of Ifnar1^−/−^ and Ifnar1^+/+^ macrophages left untreated or treated for 2 h with IFN-β alone or followed by infection for 6 h with *F. novicida* (MOI, in parentheses above lanes). (**d**) Enzyme-linked immunosorbent assay of IFN-β in culture supernatants of *Aim2*^−/−^ and *Aim2*^+/+^ macrophages left uninfected or infected for 6 h with *F. novicida* (MOI, 250). \**P* \< 0.05 and \*\**P* \< 0.005 (Student's *t*-test). (**e**) Immunoblot analysis of mouse STAT1 phosphorylated at Tyr701 (p-STAT1), total STAT1 and AIM2 in lysates of mouse *Aim2*^−/−^ and *Aim2*^+/+^ macrophages left uninfected or infected with *F. novicida* (MOI, 250). (**f**) Enzyme-linked immunosorbent assay of IFN-β in culture supernatants of *Aim2*^+/+^ macrophages left untreated or infected for 6 h with *F. novicida* (MOI, 250) in the presence (+ bafilo) or absence of bafilomycin (50 nM). \**P* \< 0.01 (Student's *t*-test). Data are representative of two (a,c) or three (b,d--f) experiments (mean and s.d. in d,f).](nihms184297f4){#F4}

![Cytoplasmic DNA secreted by *Francisella* induces AIM2 oligomerization. (**a**), Enlarged confocal live cell images of *Nlrp3*^−/−^-AIM2-EGFP-N1 BMDM following transfection with Cy-3™-labeled DNA (right panels) or nothing (control, left panels). The white arrow in the blue channel (right panels) indicates staining of the clustered cytoplasmic DNA with the blue Hoechst stain, which specifically stains DNA. (**b**), Enlarged confocal live cell images of *Nlrp3*^−/−^-AIM2-EGFP-N1 BMDM left uninfected (upper panels) or infected with *F. novicida* (lower panels) for 6 h and then stained with Hoechst stain before microscopy. The white arrow in the blue channel (lower panels) indicates staining of the AIM2-GFP cluster with the DNA-specific blue Hoechst stain. (**c**), Enlarged confocal cell images of *Nlrp3*^−/−^-AIM2-EGFP-N1 BMDM left uninfected (upper panels) or infected with Hoechst-labeled *F. novicida* (lower panels) for 6 h and then fixed on coverslips before confocal microscopy. The white arrow in the blue channel (lower panels) indicates the Hoechst-labeled *Francisella* cytoplasmic DNA. Additional representative confocal images of *Nlrp3*^−/−^-AIM2-EGFP-N1 BMDM infected with unstained or Hoechst-pre-stained *F. novicida* are shown in [supplementary Figure 11](#SD1){ref-type="supplementary-material"}. DIC, differential interference contrast. Original magnification, x40. Data are representative of at least three (a,b) or two (c) experiments.](nihms184297f5){#F5}

![The AIM2 inflammasome is critical for innate immunity against Francisella infection. (**a**), Survival of *Aim2*^+/+^ and *Aim2*^−/−^ mice injected subcutaneously with *F. novicida* (1.5 × 10^5^ CFU) (*Aim2*^+/+^ n = 9, *Aim2*^−/−^ n=9), and monitored over a period of 3 weeks. 66% of *Aim2*^+/+^ survived beyond 3 weeks post-infection. (**b**), Livers and spleens were harvested 48 h post-infection of mice subcutaneously with *F. novicida* (1.0 × 10^5^ CFU) homogenized, and dilutions plated on Cystine Heart Agar plates for enumeration of CFU. Bacterial counts from the livers and spleens of the *Aim2*^−/−^ were significantly higher compared with *Aim2*^+/+^ mice (P 0.0054, and 0.0011, respectively). (**c**) Enzyme-linked immunosorbent assay of IL-18 in serum from *Aim2*^+/+^ mice (n = 3) and *Aim2*^−/−^ mice (n = 3) at 1 d after subcutaneous infection with *F. novicida*. In b,c, each symbol represents an individual mouse; small horizontal lines indicate the mean. P values, Kaplan-Meier log-rank test (a) or Student's *t*-test (b,c). Data are representative of two experiments.](nihms184297f6){#F6}
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